Table 3.
Prevalence of PIMs per person according to the NORGEP-NH criteria
| No. of PIMs per person | NORGEP-NH A1+B2 + C3, prevalence (%), | NORGEP-NH A1+B2, prevalence (%) | No. of psychotropic drugs per person, prevalence (%) | |||
|---|---|---|---|---|---|---|
| Excl. drugs on demand | Incl. drugs on demand | Excl. drugs on demand | Incl. drugs on demand | Excl. drugs on demand | Incl. drugs on demand | |
| 0 | 108 (12.3) | 64 (7.3) | 495 (56.2) | 265 (30.1) | 267 (30.3) | 130 (14.8) |
| 1 | 253 (28.7) | 163 (18.5) | 163 (18.5) | 185 (21.0) | 290 (32.9) | 182 (20.7) |
| 2 | 211 (24.0) | 161 (18.3) | 136 (15.4) | 181 (20.5) | 196 (22.2) | 203 (23.0) |
| 3 | 142 (16.1) | 151 (17.1) | 63 (7.2) | 138 (15.7) | 86 (9.8) | 160 (18.2) |
| 4 | 80 (9.1) | 130 (14.8) | 20 (2.3) | 72 (8.2) | 37 (4.2) | 113 (12.8) |
| 5 | 52 (5.9) | 104 (11.8) | 3 (0.3) | 22 (2.5) | 4 (0.5) | 53 (6.0) |
| 6 | 26 (3.0) | 57 (6.5) | 0 | 13 (1.5) | 1 (0.1) | 29 (3.3) |
| 7 | 5 (0.6) | 29 (3.3) | 1 (0.1) | 2 (0.2) | 0 | 8 (0.9) |
| 8 | 3 (0.3) | 13 (1.5) | 0 | 3 (0.3) | 0 | 2 (0.2) |
| 9 | 0 | 3 (0.3) | 0 | 0 | 0 | 1 (0.1) |
| 10 | 1 (0.1) | 5 (0.6) | 0 | 0 | 0 | 0 |
| 11 | 0 | 1 (0.1) | 0 | 0 | 0 | 0 |
| SUM | 881 (100%) | 881 (100%) | 881 (100%) | 881 (100%) | 881 (100%) | 881 (100%) |
1A: Single substance criteria 2B: Combination criteria 3C: Deprescribing criteria
Number of people affected, with percentages